30
Participants
Start Date
May 31, 2012
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Rituximab (Mabthera®, Roche Pty Ltd, Basel, Switzerland)
Recommended and approved dosage of Rituximab is 375mg/m2. The recommended guideline for Rituximab infusion for first cycle is commencing at an infusion rate of 50mg/hr for the first 30 minutes. If tolerated well, the subsequent increments will step up to 50mg/hr every 30 minutes to a maximum dose of 400mg/hr. For second and subsequent infusions, the infusion rate commences at 100mg/hr with 30 minute increments of 100mg/hr to a maximum dose of 400mg/hr. The first and subsequent infusion generally completes between 5-6 and 3-4 hours respectively.
National University Hospital, Singapore
National University Hospital, Singapore
OTHER